Revenue Breakdown
Composition ()
No data
Revenue Streams
Becton Dickinson and Co (BDX) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Medication Delivery Solutions, accounting for 24.7% of total sales, equivalent to $1.16B. Other significant revenue streams include Medication Management Solutions and Peripheral Intervention. Understanding this composition is critical for investors evaluating how BDX navigates market cycles within the Medical Equipment, Supplies & Distribution industry.
Profitability & Margins
Evaluating the bottom line, Becton Dickinson and Co maintains a gross margin of 46.58%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 16.12%, while the net margin is -0.78%. These profitability ratios, combined with a Return on Equity (ROE) of 6.67%, provide a clear picture of how effectively BDX converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, BDX competes directly with industry leaders such as A and IDXX. With a market capitalization of $39.67B, it holds a significant position in the sector. When comparing efficiency, BDX's gross margin of 46.58% stands against A's 54.11% and IDXX's 63.35%. Such benchmarking helps identify whether Becton Dickinson and Co is trading at a premium or discount relative to its financial performance.
